FRANKLIN LAKES, N.J., Dec. 1, 2014 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that the company's presentation at the 26(th) Annual Piper Jaffray Healthcare Conference has been rescheduled to Wednesday, December 3, 2014, at 4:30 p.m. EST.

A live webcast of BD's presentation can be accessed from the BD corporate website at www.bd.com/investors and will be available for replay through Wednesday, December 10, 2014.

About BD
BD is a leading medical technology company that partners with customers and stakeholders to address many of the world's most pressing and evolving health needs. Our innovative solutions are focused on improving drug delivery, enhancing the diagnosis of infectious diseases and cancers, supporting the management of diabetes and advancing cellular research. We are nearly 30,000 associates in 50 countries who strive to fulfill our purpose of "Helping all people live healthy lives" by advancing the quality, accessibility, safety and affordability of healthcare around the world. For more information, please visit www.bd.com.

Contact:
Monique N. Dolecki, Investor Relations - 201-847-5378

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/bd-to-present-at-the-26th-annual-piper-jaffray-healthcare-conference-300002863.html

SOURCE BD (Becton, Dickinson and Company)